Monoclonal Antibodies
The Second Generation
Herausgeber: Zola, Heddy
Monoclonal Antibodies
The Second Generation
Herausgeber: Zola, Heddy
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
A review of what needs to be done to realise the potential of monoclonal antibodies. The book assesses the competing technologies with advice on the best approach for a particular situation.
Andere Kunden interessierten sich auch für
- Principles of Regenerative Medicine214,99 €
- Kenneth C. McCulloughMonoclonal Antibodies in Biotechnology218,99 €
- Monoclonal Antibodies in Diagnostic Immunohistochemistry387,99 €
- RitterMonoclonal Antibodies132,99 €
- Monoclonal Antibodies129,00 €
- KresinaMonoclonal Antibodies332,99 €
- Fathimunisa BegumMONOCLONAL ANTIBODIES29,99 €
-
-
-
A review of what needs to be done to realise the potential of monoclonal antibodies. The book assesses the competing technologies with advice on the best approach for a particular situation.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 220
- Erscheinungstermin: 26. Juni 1995
- Englisch
- Abmessung: 234mm x 156mm x 14mm
- Gewicht: 490g
- ISBN-13: 9781872748788
- ISBN-10: 1872748783
- Artikelnr.: 21593174
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Taylor & Francis
- Seitenzahl: 220
- Erscheinungstermin: 26. Juni 1995
- Englisch
- Abmessung: 234mm x 156mm x 14mm
- Gewicht: 490g
- ISBN-13: 9781872748788
- ISBN-10: 1872748783
- Artikelnr.: 21593174
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Chief Hospital Scientist and Professor of Immunology, Flinders Medical Centre and Flinders University, Adelaide, Australia.
Contributors
Abbreviations
Preface
Safety note
1. Introduction. H. Zola
Introduction: the purpose of this book
Monoclonal antibodies: scope and limitations
Antibodies as laboratory reagents: a brief perspective
Antibodies as therapeutic agents: a brief perspective
Conclusions
References
2. Making and using 'conventional' mouse monoclonal antibodies. P.J. Donohoe, P.J. Macardle and H. Zola
Introduction
Tissue culture
Materials
Working solutions
The screening assay
Immunization
The myeloma cell line
Fusion protocol
Feeder cells
Post
fusion care
Mycoplasma
Cloning
Cryopreservation
Thawing cells out
Ascites fluid
Production of monoclonal antibodies in dialysis tubing
Continuous perfusion culture systems
Purification
Conjugation
References
3. Human monoclonal antibodies from immortalized B cells. A. W. Hohmann, L. Spatz, M. Irigoyen and A. Manheimer
Lory
Introduction
Immortalized B cells to probe the human antibody repertoire
Infectious diseases
Human immunodeficiency virus
Erythrocyte antigens
Human histocompatibility antigens
Tumor antigens
Autoantibodies
Immortalization of B cells with EBV
EBV transformation of B cells: methodology
Making human hybridomas
Hybridoma methodology
References
4. Reconstruction of monoclonal antibodies by genetic engineering. J.R. Adair and D.J. King
Introduction
The reconstruction process
The binding site
The effector functions
Reconstructed antibodies in practice
Summary and conclusions
References
5. The genetic engineering of antibody constructs for diagnosis and therapy. G.A. Pietersz and l.F.C. McKenzie
Introduction
Principles of use of antibody conjugates
Recent advances in immunoconjugate construction
Recombinant antibodies and fusion proteins
Use of cytokines and growth factors for targeting
Potential problems
Conclusions
References
6. Superseding hybridoma technology with phage display libraries. R. Irving and P. Hudson
Introduction
Affinity maturation
Discussion
References
7. Construction and application of libraries of artificial antibodies. W. Ito and Y. Kurosawa
Introduction
Expression in E. coli of antibodies whose V genes are derived from V" and V L genes expressed in animals
Characteristics of phage display antibodies
Various devices for the generation of artificial antibodies
Construction of libraries of completely synthetic antibodies
Application of libraries of artificial antibodies
Future perspectives
References
8. Expression of antibody genes in mammalian cells. C. Bebbington
Introduction
Transient expression
Stable mammalian expression systems
Other factors influencing expression in mammalian cells
Choosing an expression system
References
9. Structure and application of single
chain Fvs as diagnostic and therapeutic agents. P. Hudson
Introduction
Design of single
chain Fv fragments
Construction of scFv genes
The structure of scFv fragments
The design of fusion proteins
The design of bifunctional scFvs ( diabodies)
The choice of expression systems
Scale
up production of scFvs in fermenters
Case studies: the design and expression of scFv molecules (for crystal structures and novel diagnostics)
Applications of scFvs in diagnostics
Discussion
References
Index.
Abbreviations
Preface
Safety note
1. Introduction. H. Zola
Introduction: the purpose of this book
Monoclonal antibodies: scope and limitations
Antibodies as laboratory reagents: a brief perspective
Antibodies as therapeutic agents: a brief perspective
Conclusions
References
2. Making and using 'conventional' mouse monoclonal antibodies. P.J. Donohoe, P.J. Macardle and H. Zola
Introduction
Tissue culture
Materials
Working solutions
The screening assay
Immunization
The myeloma cell line
Fusion protocol
Feeder cells
Post
fusion care
Mycoplasma
Cloning
Cryopreservation
Thawing cells out
Ascites fluid
Production of monoclonal antibodies in dialysis tubing
Continuous perfusion culture systems
Purification
Conjugation
References
3. Human monoclonal antibodies from immortalized B cells. A. W. Hohmann, L. Spatz, M. Irigoyen and A. Manheimer
Lory
Introduction
Immortalized B cells to probe the human antibody repertoire
Infectious diseases
Human immunodeficiency virus
Erythrocyte antigens
Human histocompatibility antigens
Tumor antigens
Autoantibodies
Immortalization of B cells with EBV
EBV transformation of B cells: methodology
Making human hybridomas
Hybridoma methodology
References
4. Reconstruction of monoclonal antibodies by genetic engineering. J.R. Adair and D.J. King
Introduction
The reconstruction process
The binding site
The effector functions
Reconstructed antibodies in practice
Summary and conclusions
References
5. The genetic engineering of antibody constructs for diagnosis and therapy. G.A. Pietersz and l.F.C. McKenzie
Introduction
Principles of use of antibody conjugates
Recent advances in immunoconjugate construction
Recombinant antibodies and fusion proteins
Use of cytokines and growth factors for targeting
Potential problems
Conclusions
References
6. Superseding hybridoma technology with phage display libraries. R. Irving and P. Hudson
Introduction
Affinity maturation
Discussion
References
7. Construction and application of libraries of artificial antibodies. W. Ito and Y. Kurosawa
Introduction
Expression in E. coli of antibodies whose V genes are derived from V" and V L genes expressed in animals
Characteristics of phage display antibodies
Various devices for the generation of artificial antibodies
Construction of libraries of completely synthetic antibodies
Application of libraries of artificial antibodies
Future perspectives
References
8. Expression of antibody genes in mammalian cells. C. Bebbington
Introduction
Transient expression
Stable mammalian expression systems
Other factors influencing expression in mammalian cells
Choosing an expression system
References
9. Structure and application of single
chain Fvs as diagnostic and therapeutic agents. P. Hudson
Introduction
Design of single
chain Fv fragments
Construction of scFv genes
The structure of scFv fragments
The design of fusion proteins
The design of bifunctional scFvs ( diabodies)
The choice of expression systems
Scale
up production of scFvs in fermenters
Case studies: the design and expression of scFv molecules (for crystal structures and novel diagnostics)
Applications of scFvs in diagnostics
Discussion
References
Index.
Contributors
Abbreviations
Preface
Safety note
1. Introduction. H. Zola
Introduction: the purpose of this book
Monoclonal antibodies: scope and limitations
Antibodies as laboratory reagents: a brief perspective
Antibodies as therapeutic agents: a brief perspective
Conclusions
References
2. Making and using 'conventional' mouse monoclonal antibodies. P.J. Donohoe, P.J. Macardle and H. Zola
Introduction
Tissue culture
Materials
Working solutions
The screening assay
Immunization
The myeloma cell line
Fusion protocol
Feeder cells
Post
fusion care
Mycoplasma
Cloning
Cryopreservation
Thawing cells out
Ascites fluid
Production of monoclonal antibodies in dialysis tubing
Continuous perfusion culture systems
Purification
Conjugation
References
3. Human monoclonal antibodies from immortalized B cells. A. W. Hohmann, L. Spatz, M. Irigoyen and A. Manheimer
Lory
Introduction
Immortalized B cells to probe the human antibody repertoire
Infectious diseases
Human immunodeficiency virus
Erythrocyte antigens
Human histocompatibility antigens
Tumor antigens
Autoantibodies
Immortalization of B cells with EBV
EBV transformation of B cells: methodology
Making human hybridomas
Hybridoma methodology
References
4. Reconstruction of monoclonal antibodies by genetic engineering. J.R. Adair and D.J. King
Introduction
The reconstruction process
The binding site
The effector functions
Reconstructed antibodies in practice
Summary and conclusions
References
5. The genetic engineering of antibody constructs for diagnosis and therapy. G.A. Pietersz and l.F.C. McKenzie
Introduction
Principles of use of antibody conjugates
Recent advances in immunoconjugate construction
Recombinant antibodies and fusion proteins
Use of cytokines and growth factors for targeting
Potential problems
Conclusions
References
6. Superseding hybridoma technology with phage display libraries. R. Irving and P. Hudson
Introduction
Affinity maturation
Discussion
References
7. Construction and application of libraries of artificial antibodies. W. Ito and Y. Kurosawa
Introduction
Expression in E. coli of antibodies whose V genes are derived from V" and V L genes expressed in animals
Characteristics of phage display antibodies
Various devices for the generation of artificial antibodies
Construction of libraries of completely synthetic antibodies
Application of libraries of artificial antibodies
Future perspectives
References
8. Expression of antibody genes in mammalian cells. C. Bebbington
Introduction
Transient expression
Stable mammalian expression systems
Other factors influencing expression in mammalian cells
Choosing an expression system
References
9. Structure and application of single
chain Fvs as diagnostic and therapeutic agents. P. Hudson
Introduction
Design of single
chain Fv fragments
Construction of scFv genes
The structure of scFv fragments
The design of fusion proteins
The design of bifunctional scFvs ( diabodies)
The choice of expression systems
Scale
up production of scFvs in fermenters
Case studies: the design and expression of scFv molecules (for crystal structures and novel diagnostics)
Applications of scFvs in diagnostics
Discussion
References
Index.
Abbreviations
Preface
Safety note
1. Introduction. H. Zola
Introduction: the purpose of this book
Monoclonal antibodies: scope and limitations
Antibodies as laboratory reagents: a brief perspective
Antibodies as therapeutic agents: a brief perspective
Conclusions
References
2. Making and using 'conventional' mouse monoclonal antibodies. P.J. Donohoe, P.J. Macardle and H. Zola
Introduction
Tissue culture
Materials
Working solutions
The screening assay
Immunization
The myeloma cell line
Fusion protocol
Feeder cells
Post
fusion care
Mycoplasma
Cloning
Cryopreservation
Thawing cells out
Ascites fluid
Production of monoclonal antibodies in dialysis tubing
Continuous perfusion culture systems
Purification
Conjugation
References
3. Human monoclonal antibodies from immortalized B cells. A. W. Hohmann, L. Spatz, M. Irigoyen and A. Manheimer
Lory
Introduction
Immortalized B cells to probe the human antibody repertoire
Infectious diseases
Human immunodeficiency virus
Erythrocyte antigens
Human histocompatibility antigens
Tumor antigens
Autoantibodies
Immortalization of B cells with EBV
EBV transformation of B cells: methodology
Making human hybridomas
Hybridoma methodology
References
4. Reconstruction of monoclonal antibodies by genetic engineering. J.R. Adair and D.J. King
Introduction
The reconstruction process
The binding site
The effector functions
Reconstructed antibodies in practice
Summary and conclusions
References
5. The genetic engineering of antibody constructs for diagnosis and therapy. G.A. Pietersz and l.F.C. McKenzie
Introduction
Principles of use of antibody conjugates
Recent advances in immunoconjugate construction
Recombinant antibodies and fusion proteins
Use of cytokines and growth factors for targeting
Potential problems
Conclusions
References
6. Superseding hybridoma technology with phage display libraries. R. Irving and P. Hudson
Introduction
Affinity maturation
Discussion
References
7. Construction and application of libraries of artificial antibodies. W. Ito and Y. Kurosawa
Introduction
Expression in E. coli of antibodies whose V genes are derived from V" and V L genes expressed in animals
Characteristics of phage display antibodies
Various devices for the generation of artificial antibodies
Construction of libraries of completely synthetic antibodies
Application of libraries of artificial antibodies
Future perspectives
References
8. Expression of antibody genes in mammalian cells. C. Bebbington
Introduction
Transient expression
Stable mammalian expression systems
Other factors influencing expression in mammalian cells
Choosing an expression system
References
9. Structure and application of single
chain Fvs as diagnostic and therapeutic agents. P. Hudson
Introduction
Design of single
chain Fv fragments
Construction of scFv genes
The structure of scFv fragments
The design of fusion proteins
The design of bifunctional scFvs ( diabodies)
The choice of expression systems
Scale
up production of scFvs in fermenters
Case studies: the design and expression of scFv molecules (for crystal structures and novel diagnostics)
Applications of scFvs in diagnostics
Discussion
References
Index.